Healthy subjects
Conditions
Interventions
Administration of Acanthopanax senticosus Harms during 12 weeks.
Administration of placebo during 12 weeks.
Sponsors
Suzuka University of Medicinal Science
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1)Healthy Subjects. 2)Males and females over 18 years old at the time of obtaining consent. 3)Persons who have provided written consent to participate in the study.
Exclusion criteria
Exclusion criteria: 1)Persons who have ingested foods containing Acanthopanax senticosus Harms within 3 months. 2)Persons who comsume health foods or supplements that may affect the study results. 3)Persons with allergies to Acanthopanax senticosus Harms. 4)Persons who are in hospital, on mdication, or undergoing treatment. 5)Persons with alcohol dependence. 6)Persons participating in other clinical studies. 7)Persons with a history of sever hepatic, renal, or cardiac disorders. 8)Persons with pre-existing or current hepatitis. 9)Persons with sever anemia. 10)Persons with hypertension (systolic blood pressure: 180 mmHg or higher, diastolic blood pressure: 90 mmHg or higher). 11)Persons deemed by the principal investigater and sub-investigater to be inappropriate to participate in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Before Administration, after 1 month, after 2 months 1)Questionnaires about health condition 2)General Self-Efficacy Scale (GSES) 3)OSA Sleep inventory 4)STAI | — |
Secondary
| Measure | Time frame |
|---|---|
| Before Administration, after 1 month, after 2 months 1)Salivary Amylase 2)Salivary Cortisol 3)Autonomic activity | — |
Countries
Japan
Contacts
Public ContactHideo Takekoshi
Sun Chlorella Corp. Production & Development Department
Outcome results
None listed